Prenatal Testing and Newborn Screening Market to Record Steadfast Evolution Through 2020-2027

According to a recent report by Emergen Research, the global prenatal testing and newborn screening market is expected to be worth USD 10.85 billion by 2027. Due to its expanding use in identifying fetal chromosomal abnormalities, prenatal testing and newborn screening are in high demand. Prenatal testing is thought to be better than other screening methods, especially for trisomy 21. (one of the most prevalent congenital anomalies). Individuals can use prenatal testing to decide for themselves whether diagnostic testing is necessary. The genetic material that is present or absent in associated fetal chromosomal abnormalities can range from tiny portions of chromosomes to complete chromosomes.

The market for prenatal testing and newborn screening is driven by growing demand among expectant mothers as an alternative to amniocentesis and knowledge of genetic issues in the fetus and newborn newborns.

The prenatal testing and newborn screening market, which is expanding rapidly, is the subject of this study. The research provides a roadmap for the prenatal testing and newborn screening market, which will influence how we live in the coming ten years and beyond. It also discusses how the market will respond to the threat of the global pandemic.

Some Key Highlights from the Report

  •       A non-invasive, tailored prenatal test for monogenetic illnesses called the Resura Prenatal Test was announced by Progenity Inc. in April 2019.
  •       Due to the potential of ultrasound diagnosis to detect irregularities in the location of the fetus and actions within the womb, ultrasound technology is expected to see a large growth rate during the projection period.
  •       Due to the expanding use of non-invasive prenatal testing, quick technological advancements in newborn screening, the presence of qualified personnel, and better reimbursement conditions, the hospital held a sizable market share in 2019.
  •       Due to the availability of cutting-edge healthcare research systems and advancements in whole-genome sequencing, North America dominated the market for prenatal testing and newborn screening in 2019.

The market’s attributes, size and growth, segmentation, regional and national breakdowns, competitive environment, market shares, trends, and strategies are all included in the study. It charts the market’s historical and anticipated geographic growth. It compares the market to other markets and situates it within the larger prenatal testing & newborn screening market.

Key participants include:

Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

The study goes into great detail on the Prenatal Testing and Newborn Screening market’s growth prospects, difficulties, market drivers and restraints, constraints, risks, and needs. To have a better understanding of the market’s size, the study also evaluates the regional and global markets. Additionally, the study provides estimates and projections regarding the market segment and sub-segments showing promising growth throughout the course of the forecast year. A better understanding of the technological developments, industrial environment, and new product and technological developments in the Prenatal Testing and Newborn Screening market is also provided by the research. In order to help organizations take advantage of the attractive growth opportunities, it provides insightful knowledge into the business world.

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Prenatal Testing
  • Newborn Screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Non-Invasive
  • Invasive

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Mass Spectrometry
  • Electrophoresis
  • Enzyme Immunoassays
  • DNA Assays

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Ultrasonography
  • Reagent and Assay Kits
  • Tandem Quadrupole Detector
  • Incubator Shaker
  • Hearing Screen Instruments

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers

Browse the complete Global Prenatal Testing and Newborn Screening Market Research Report – Industry Analysis, Size, Share, Growth, Trends@ Visit Us